glp-1 conference food beverage retail fitness speaking opportunities [WEBINAR] How drugs change the game for and beverage, retail, travel and beyond Consumers Taking GLP-1s for Weight

The challenge is that when used correctly requires medical oversight, quality sourcing, and legal compliancethree things many peptide sellers ignore

In available clinical trial data, gallstones were reported in roughly 12.5% of patients taking GLP-1 tablets, compared with around 0.71% on placebo

Between family gatherings, festive treats, and packed schedules, its easy to let health goals take a backseat

Research published in PNAS indicates that patients with Long COVID and ME/CFS exhibit signs of elevated oxidative stress and aberrations in ROS clearance pathways, including elevated glutathione levels in peripheral blood lymphocytes and decreased mitochondrial superoxide dismutase